L

A

LARDY-CLÉAUD , A.

Last name: LARDY-CLÉAUD

First name: A.

May 2018 (v1)

Journal article

Metadata-only

Endocrine therapy or chemotherapy as first-line therapy in hormone receptor–positive HER2-negative metastatic breast cancer patients

Jacquet, E. Lardy-Cléaud, A. Pistilli, B.

BACKGROUND:For hormone receptor-positive (HR+) human epidermal growth factor receptor 2 (HER2-) negative metastatic breast cancer (MBC), international guidelines recommend endocrine therapy as first-line treatment, except in case of 'visceral crisis'. In the latter case, chemotherapy is preferred. Few studies have compared these two strategies....

Uploaded on: December 4, 2022